logo-loader

Buds & Duds: Cannabis stocks off to rocky start ahead of much-anticipated earnings this week

Investors are gearing up for quarterly results from the four largest Canadian cannabis companies this week

hemp field
Standouts on the day included Aleafia Health, Nabis Holdings and GSRX Industries

Cannabis stocks tumbled on Monday ahead of a big week of earnings that may set the tone for the marijuana market in North America.

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, slipped 1.7% at 130.3 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF fell 3.1% higher to C$10.46, while the OTCQX Cannabis Index lost 0.4% at 469.8 points.

This week, investors can expect results from the four largest Canadian cannabis companies. Canopy Growth Corp (TSE:WEED) (NYSE:CGC) and Aurora Cannabis Inc (TSE:ACB) (NYSE:ACB) report third-quarter earnings on Thursday, while Cronos Group Inc (TSE:CRON) (NASDAQ:CRON), MediPharm Labs Corp (TSE:LABS) (OTCMTKS:MEDIF), and Acreage Holdings Inc (CSE:ACRG.U) (OTCMKTS:ACRGF) will post results on Tuesday.

Buds

Canada’s Aleafia Health Inc (TSE:ALEF) (OTCMKTS:ALEAF) kicked off the week telling investors that the cultivator’s Port Perry, Ontario harvest yielded 10.300 kilograms of dried flower at a cost of C$0.08 per gram, putting it among the lowest-cost pot producers.

Shares of Aleafia grew 7.4% in Canada at C$0.87 and 7.2% on OTC markets at US$0.66.

Aleafia reports its third-quarter results on Tuesday premarket.

After reporting strong results last week, cannabis data analytics company CB2 Insights Inc (CSE:CBII) (OTCMKTS:CBIIF) continued to trade higher, up 20% on Monday morning at C$0.15 in Canada and 8% on OTC markets at US$0.11.

US cannabis operator Nabis Holdings Inc (CSE:NAB) (OTCMKTS:NABIF) also gained on Monday on no new news. The company’s stock rose 21.5% at C$0.09 in Canada and 12.3% on the OTC Pink market at US$0.07.

Vertically integrated Puerto Rico company GSRX Industries Inc (OTCMKTS:GSRX) was also up 35% at US$0.14.

Duds

Cannabis investors should brace themselves for what might be a rocky week in marijuana markets as earnings will provide shareholders a clearer picture of the path towards profitability for many of the sector’s big players.

In perhaps a sign of things to come this week, Neptune Wellness Solutions Inc (TSE:NEPT) (NASDAQ:NEPT) released its fiscal second-quarter results that saw its loss widen and sales decrease.

The company posted a net loss of nearly C$21 million compared to last year’s C$3 million figure.

Investors sent Neptune’s stock into the red by midmorning Monday, down 9.5% in Toronto at C$4.27 and 8.2% in the US at US$3.25.

Also reporting was GrowGeneration Corp (OTCMKTS:GRWG), which fell 6% at US$4.49 despite swinging to a profit in 3Q.

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Ontario's cannabis retail expansion plan gives cannabis stocks...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, was 1.4% higher at 116.7 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF jumped 2.4% at C$9.55, while the OTCQX Cannabis index gained 0.6% to 434 points. Buds today are The Green...

1 day, 21 hours ago

3 min read